Anna Ianiro

Dr. Anna Ianiro

IRCCS REGINA ELENA NATIONAL CANCER INSTITUTE, Rome, Lazio, Italy

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2023 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
EIErminia Infusino
Erminia Infusino
AIAnna Ianiro
Anna Ianiro
SLStefano Luppino
Stefano Luppino
SNSandro Nocentini
Sandro Nocentini
CPCristina Pugliatti
Cristina Pugliatti
ASAntonella No Soriani
Antonella No Soriani
Purpose: We validate the routine use of a two‐dimensional (2D) diode matrix for patient specific pre‐treatment verification for Cyberknife (CK) stereotactic radiosurgery and to compare it with film dosimetry.Materials and method: A total of 46 patients were selected according to the most frequent diseases treated at our institution with the CK system, that is, brain metastases, meningiomas, spine metastases, and prostate tumors. All cases were evaluated with GAFChromic EBT‐3 films and SRS MapCHECK for Fixed cone, IRIS, and MLC collimators of the CK.Results: The highest mean passing rate was observed for the SRS MapCHECK system compared to films. In order to assess if the two techniques provide statistically different results, a Wilcoxon Signed‐Rank non‐parametric test was performed (p < 0.05) and we found gamma values significantly lower for EBT‐3 films with respect to the SRS MapCHECK. We noticed a moderately significant association between the two techniques using Spearman's rank correlation coefficient (rs > 0.4). We also performed the Bland–Altman statistical method: less than 5% of the differences resulted outside the range (mean ± 1.96 × SD), so the two methods can be considered interchangeable within the combined inaccuracy.Conclusions: The use of SRS MapCHECK for CK patient specific quality assurance (QA) is feasible for a variety of clinical districts and could be reliably used as a replacement for radiochromic films.

1 January 2017 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
MFMarica Ferro
Marica Ferro
SCSilvia Chiesa
Silvia Chiesa
Gabriella MacchiaGabriella Macchia
Gabriella Macchia
Savino CillaSavino Cilla
Savino Cilla
FBFederica Bertini
Federica Bertini
Alessio Giuseppe MorgantiAlessio Giuseppe Morganti
Alessio Giuseppe Morganti

1 April 2023 in Journal of Medical Physics
Verified
Journal Article
Open access
AIAnna Ianiro
Anna Ianiro
EIErminia Infusino
Erminia Infusino
MDMarco D’aNdrea
Marco D’aNdrea
LMLaura Marucci
Laura Marucci
AFAlessia Farneti
Alessia Farneti
ASAntonella Soriani
Antonella Soriani
Purpose: In our institution, stereotactic radiosurgery of multiple brain metastases is performed with the CyberKnife® (CK) device, using fixed/Iris collimators. In this study, nineteen fixed/Iris plans were recalculated with the multileaf collimator (MLC), to assess if it is possible to produce plans with comparable dosimetric overall quality. Materials and Methods: For consistent comparisons, MLC plans were re-optimized and re-normalized in order to achieve the same minimum dose for the total planning target volume (PTVtot). Conformation number (CN), homogeneity index (HI) and dose gradient index (DGI) metrics were evaluated. The dose to the brain was evaluated as the volume receiving 12 Gy (V12) and as the integral dose (ID). The normal tissue complication probability (NTCP) for brain radionecrosis was calculated as a function of V12. Results: The reoptimized plans were reviewed by the radiation oncologist and were found clinically acceptable according to the The American Association of Physicists in Medicine (AAPM) Task Group-101 protocol. However, fixed/Iris plans provided significantly higher CN (+8.6%), HI (+2.2%), and DGI (+44.0%) values, and significantly lower ID values (−35.9%). For PTVtot less than the median value of 2.58cc, fixed/Iris plans provided significantly lower NTCP values. On the other side, MLC plans provided significantly lower treatment times (−18.4%), number of monitor units (−33.3%), beams (−46.0%) and nodes (−21.3%). Conclusions: CK-MLC plans for the stereotactic treatment of brain multi metastases could provide an important advantage in terms of treatment duration. However, to contain the increased risk for brain radionecrosis, it could be useful to calculate MLC plans only for patients with large PTVtot.

13 March 2024 in Physica Medica
Verified
Journal Article
Closed access
RCRoberta Castriconi
Roberta Castriconi
ATAlessia Tudda
Alessia Tudda
LPLorenzo Placidi
Lorenzo Placidi
GBGiovanna Benecchi
Giovanna Benecchi
ECElisabetta Cagni
Elisabetta Cagni
Claudio FiorinoClaudio Fiorino
Claudio Fiorino

5 September 2024 in Current Oncology
Verified
Journal Article
Open access
PDF file
STSilvia Takanen
Silvia Takanen
AIAnna Ianiro
Anna Ianiro
PPPaola Pinnarò
Paola Pinnarò
EIErminia Infusino
Erminia Infusino
LMLaura Marucci
Laura Marucci
GIGiuseppe Iaccarino
Giuseppe Iaccarino
Background: In high-risk breast cancer patients with skin infiltration, the administration of a uniform dose to superficial tissues is fundamental in order to reduce local skin relapse. A personalized bolus may prevent the potential inadequate dose distribution of a standard bolus due to air gaps between the bolus and the skin. In this pilot study, we introduced into clinical practice the use of a personalized 3D-printed bolus filled with ultrasound transmission gel. Methods: Seven patients undergoing radiotherapy after mastectomy were selected. A 3D-printed bolus dosimetric assessment was performed with MOSFET dosimeters on an anthropomorphic phantom and, subsequently, on three selected cases with increasing bolus shape irregularity. Acute/late toxicity and local control were assessed. Results: Overall, for the clinical cases, the percentage median difference between the measured and calculated doses was −2.7% (−7.0–4.9%). The median follow-up was 21 months. After two years, one patient showed G2 pain, one patient manifested G1 telangiectasia, one patient showed G1 hyperpigmentation, and two patients had no relevant toxicity. Conclusions: A personalized 3D-printed bolus filled with ultrasound gel may easily reproduce the standard bolus’ consistency and provide accurate coverage of the target area with tolerable acute/late toxicity grades. This is a pilot study, and further investigations are needed.

19 October 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
SUSara Ungania
Sara Ungania
MDMarco D’Arienzo
Marco D’Arienzo
EMEmilio Mezzenga
Emilio Mezzenga
GPGiuseppe Pizzi
Giuseppe Pizzi
GVGiulio Eugenio Vallati
Giulio Eugenio Vallati
LSLidia Strigari
Lidia Strigari
At a time of increasing evidence for dose-effect relationships in radioembolization (RE) with 90Y-microspheres, the general consensus is that there is an urgent need for accurate treatment planning and dose assessment in patients undergoing RE treatment. This work aimed at assessing the usefulness of 99mTc macroaggregated albumin (MAA) SPECT/CT imaging for personalized provisional RE dosimetry considering a 3D-printed patientlike phantom (AdboMan phantom). A homemade tool was developed in MATLAB for image analysis and absorbed dose calculation. Two dose calculaton methods were implemented and used to calculate dose volume histograms: (I) dose kernel method and (II) local energy deposition method. The accuracy of the two different dosimetric methods was evaluated by means of 3D γ-index (1%–1 mm and 2%–2 mm) implemented in the tool. Differences between the two dose calculation methods using the 3D γ-index are within 1%–1 mm and 2%–2 mm for all AbdoMan inserts, with a passing rate of 99.9% and 100%, respectively, proving a good agreement between the two calculation methods. The present study supports the use of 99mTc-MAA SPECT acquisition for provisional dosimetry along with the local energy deposition method to convert reconstructed SPECT data into absorbed dose maps. As long as 99mTc-MAA SPECT acquisitions are performed on liver lesions larger than 40 mm, the absorbed dose computed by means of the local energy deposition method can lead to results in line with those obtained by Monte Carlo calculations.